NCT05859334 2026-03-18
Testing the Anti-cancer Drug Erdafitinib for Brain Cancers That Have Returned or Progressed Following Treatment
National Cancer Institute (NCI)
Phase 2 Recruiting
Clinical Trials
4 trialsNCT05316155 2026-03-13
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
Janssen Research & Development, LLC
Phase 1/2 Recruiting
NCT06319820 2026-03-13
MoonRISe-1
Janssen Research & Development, LLC
Phase 3 Recruiting
NCT06919965 2026-03-13
MoonRISe-3
Janssen Research & Development, LLC
Phase 3 Recruiting